Comparative Cardiovascular Risks of Radical Prostatectomy and External Beam Radiation Therapy in Early-Stage Prostate Cancer: A Comprehensive Retrospective Analysis

被引:1
|
作者
Shan, Jiahao [1 ]
Liu, Ziyang [1 ]
Yu, Jin [1 ]
Zhang, Qiang [2 ]
Shi, Hongbin [2 ]
Ma, Lianghong [2 ,3 ,4 ]
机构
[1] Ningxia Med Univ, Clin Med Coll 1, Yinchuan, Peoples R China
[2] Ningxia Med Univ, Gen Hosp, Dept Urol, Yinchuan, Peoples R China
[3] Ningxia Med Univ, Inst Med Sci, Ningxia Human Sperm Bank, Gen Hosp, Yinchuan, Peoples R China
[4] Ningxia Med Univ, Key Lab Fertil Preservat & Maintenance, Minist Educ, Yinchuan, Peoples R China
关键词
Radical prostatectomy; Prostate cancer; Prognosis; Cardiac-specific mortality; Propensity score matching; UNITED-STATES; MORTALITY; STATISTICS; ASSOCIATION; DISEASE; MEN;
D O I
10.1245/s10434-024-15982-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The risk of cardiac disease mortality has recently become a focal point of concern within the medical community for patients with prostate cancer (PCa). Given that radical prostatectomy (RP) and external beam radiation therapy (EBRT) are the main treatment modalities for localized PCa, their specific impact on cardiovascular-specific mortality (CSM) remains unclear. This study explored the specific effects of RP and EBRT on CSM risk to guide clinical treatment decisions. Methods. Data from patients aged 45-74 years, who were diagnosed with T1-2N0M0 stage PCa from the SEER database (2010-2015), were used. Multivariate statistical methods, including propensity score matching (PSM), competing risk regression, COX regression analysis, and Fine-Gray testing, were applied to assess the impact of RP and EBRT on CSM risk. Results. Among 146,082 T1-2 stage PCa patients, cardiac disease emerged as the primary cause of death, surpassing PCa itself. Multifactorial COX regression and competing risk regression analyses indicated that local treatments do not increase CSM risk. Further analysis revealed a significant increase in CSM risk for patients undergoing only EBRT compared with those undergoing only RP (hazard ratio [HR] = 2.71, 95% confidence interval [CI] 1.96-3.74, P < 0.001), with subsequent PSM adjustment, further confirming a significantly reduced risk in the RP treatment group (HR 0.23, 95% CI 0.13-0.40, P < 0.001). Conclusions. T1-2 stage PCa patients face a significant risk of CSM, with RP offering a potential advantage over EBRT in reducing this risk. These findings encourage clinicians to comprehensively consider the potential impact on cardiac health when formulating treatment plans, providing crucial guidance for optimizing treatment strategies.
引用
收藏
页码:8427 / 8437
页数:11
相关论文
共 50 条
  • [31] External-beam radiation therapy increases the rate of secondary malignancies relative to radical prostatectomy in men with prostate cancer
    Bhojani, Naeem
    Jeldres, Claudio
    Da Pozzo, Luigi F.
    Morgan, Monica
    Shariat, Shahrokh F.
    Perrotte, Paul
    Suardi, Nazareno
    Saad, Fred
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 113 - 113
  • [32] THE EFFECT OF RADICAL PROSTATECTOMY, EXTERNAL BEAM RADIATION THERAPY, AND ACTIVE SURVEILLANCE ON LIFE INSURANCE PREMIUMS IN PATIENTS WITH PROSTATE CANCER
    Biebel, Mark
    Piecuch, Michael
    Stock, Jeffrey
    George, Hank
    Wright, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04): : E152 - E152
  • [33] External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study
    van der Starre, Caroline M.
    Bangma, Chris H.
    Bijlsma, Maarten J.
    van den Bergh, Alfons C. M.
    Kiemeney, Lambertus A. L. M.
    Kievit, Wietske
    Vos, Kees
    Somford, Diederik M.
    Wildeman, Sally M.
    Aben, Katja K. H.
    de Jong, Igle J.
    Pos, Floris J.
    Heesterman, Berdine L.
    BMC CANCER, 2025, 25 (01)
  • [34] External-beam radiation therapy increases the rate of secondary malignancies relative to radical prostatectomy in men with prostate cancer
    Suardi, N.
    Jeldres, C.
    Perrotte, P.
    Da Pozzo, L. F.
    Raber, M.
    Shariat, S.
    Saad, F.
    Montorsi, F.
    Karakiewicz, P. I.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 117 - 117
  • [35] Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy
    Namiki, Shunichi
    Ishidoya, Shigeto
    Kawamura, Sadafumu
    Tochigi, Tatsuo
    Arai, Yoichi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (03) : 379 - 386
  • [36] Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy
    Shunichi Namiki
    Shigeto Ishidoya
    Sadafumu Kawamura
    Tatsuo Tochigi
    Yoichi Arai
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 379 - 386
  • [37] THE ROLE OF EXTERNAL BEAM RADIATION-THERAPY AFTER PROSTATECTOMY FOR PROSTATE-CANCER
    HANKS, GE
    DAWSON, AK
    CANCER, 1986, 58 (11) : 2406 - 2410
  • [38] Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy-a claims data analysis
    Brandes, Alina
    Koerber, Florian
    Schwarzkopf, Larissa
    Hunger, Matthias
    Rogowski, Wolf H.
    Waidelich, Raphaela
    BMC HEALTH SERVICES RESEARCH, 2016, 16 : 1 - 8
  • [39] Re: Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis
    Donaldson, James F.
    McNeill, S. Alan
    EUROPEAN UROLOGY, 2016, 70 (03) : 542 - 542
  • [40] A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients
    Vapiwala, Neha
    Wong, J. Karen
    Handorf, Elizabeth
    Paly, Jonathan
    Grewal, Amardeep
    Tendulkar, Rahul
    Godfrey, Devon
    Carpenter, David
    Mendenhall, Nancy P.
    Henderson, Randal H.
    Stish, Bradley J.
    Vargas, Carlos
    Salama, Joseph K.
    Davis, Brian J.
    Horwitz, Eric M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (04): : 1082 - 1089